BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mroz MS, Lajczak NK, Goggins BJ, Keely S, Keely SJ. The bile acids, deoxycholic acid and ursodeoxycholic acid, regulate colonic epithelial wound healing. Am J Physiol Gastrointest Liver Physiol. 2018;314:G378-G387. [PMID: 29351391 DOI: 10.1152/ajpgi.00435.2016] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 3.8] [Reference Citation Analysis]
Number Citing Articles
1 Ning L, Lou X, Zhang F, Xu G. Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease. Mediators Inflamm 2019;2019:2624941. [PMID: 30804707 DOI: 10.1155/2019/2624941] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
2 Liang J, Shao W, Liu Q, Lu Q, Gu A, Jiang Z. Single Cell RNA-Sequencing Reveals a Murine Gallbladder Cell Transcriptome Atlas During the Process of Cholesterol Gallstone Formation. Front Cell Dev Biol 2021;9:714271. [PMID: 34650971 DOI: 10.3389/fcell.2021.714271] [Reference Citation Analysis]
3 Anderson KM, Gayer CP. The Pathophysiology of Farnesoid X Receptor (FXR) in the GI Tract: Inflammation, Barrier Function and Innate Immunity. Cells 2021;10:3206. [PMID: 34831429 DOI: 10.3390/cells10113206] [Reference Citation Analysis]
4 Herrnreiter CJ, Li X, Luck ME, Zilliox MJ, Choudhry MA. Integrated analysis of dysregulated microRNA and mRNA expression in intestinal epithelial cells following ethanol intoxication and burn injury. Sci Rep 2021;11:20213. [PMID: 34642361 DOI: 10.1038/s41598-021-99281-1] [Reference Citation Analysis]
5 Keely SJ, Steer CJ, Lajczak-McGinley NK. Ursodeoxycholic acid: a promising therapeutic target for inflammatory bowel diseases? Am J Physiol Gastrointest Liver Physiol 2019;317:G872-81. [PMID: 31509435 DOI: 10.1152/ajpgi.00163.2019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
6 Zhang Y, Li JX, Zhang Y, Wang YL. Intestinal microbiota participates in nonalcoholic fatty liver disease progression by affecting intestinal homeostasis . World J Clin Cases 2021; 9(23): 6654-6662 [PMID: 34447812 DOI: 10.12998/wjcc.v9.i23.6654] [Reference Citation Analysis]
7 Su J, He Z, Yu Y, Lu M, Wu Z, Zhang D. Gualou Xiebai Decoction ameliorates increased Caco-2 monolayer permeability induced by bile acids via tight junction regulation, oxidative stress suppression and apoptosis reduction. J Bioenerg Biomembr 2021. [PMID: 34718922 DOI: 10.1007/s10863-021-09927-y] [Reference Citation Analysis]
8 Burns GL, Hoedt EC, Walker MM, Talley NJ, Keely S. Physiological mechanisms of unexplained (functional) gastrointestinal disorders. J Physiol 2021. [PMID: 34705270 DOI: 10.1113/JP281620] [Reference Citation Analysis]
9 Alhouayek M, Ameraoui H, Muccioli GG. Bioactive lipids in inflammatory bowel diseases - From pathophysiological alterations to therapeutic opportunities. Biochim Biophys Acta Mol Cell Biol Lipids 2021;1866:158854. [PMID: 33157277 DOI: 10.1016/j.bbalip.2020.158854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
10 Li C, Zhang S, Li L, Hu Q, Ji S. Ursodeoxycholic Acid Protects Against Arsenic Induced Hepatotoxicity by the Nrf2 Signaling Pathway. Front Pharmacol. 2020;11:594496. [PMID: 33178028 DOI: 10.3389/fphar.2020.594496] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Azuma Y, Uchiyama K, Sugaya T, Yasuda T, Hashimoto H, Kajiwara-Kubota M, Sugino S, Kitae H, Torii T, Mizushima K, Doi T, Inoue K, Dohi O, Yoshida N, Kamada K, Ishikawa T, Takagi T, Konishi H, Naito Y, Itoh Y. Deoxycholic acid delays the wound healing of colonic epithelial cells via transmembrane G-protein-coupled receptor 5. J Gastroenterol Hepatol 2021. [PMID: 34477242 DOI: 10.1111/jgh.15676] [Reference Citation Analysis]
12 Zhao YN, Xu CP. Etiology, pathogenesis, diagnosis and treatment of bile reflux gastritis. Shijie Huaren Xiaohua Zazhi 2018; 26(32): 1886-1892 [DOI: 10.11569/wcjd.v26.i32.1886] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Zheng JD, He Y, Yu HY, Liu YL, Ge YX, Li XT, Li X, Wang Y, Guo MR, Qu YL, Qin XF, Jiang MS, Wang XH. Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation. World J Gastroenterol 2019; 25(15): 1865-1878 [PMID: 31057300 DOI: 10.3748/wjg.v25.i15.1865] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 5.7] [Reference Citation Analysis]
14 Li S, Zheng M, Zhang Z, Peng H, Dai W, Liu J. Galli gigeriae endothelium corneum: its intestinal barrier protective activity in vitro and chemical composition. Chin Med 2021;16:22. [PMID: 33593395 DOI: 10.1186/s13020-021-00432-3] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Vidal JE, Wier MN, A Angulo-Zamudio U, McDevitt E, Jop Vidal AG, Alibayov B, Scasny A, Wong SM, Akerley BJ, McDaniel LS. Prophylactic Inhibition of Colonization by Streptococcus pneumoniae with the Secondary Bile Acid Metabolite Deoxycholic Acid. Infect Immun 2021;89:e0046321. [PMID: 34543118 DOI: 10.1128/IAI.00463-21] [Reference Citation Analysis]
16 Loke YL, Chew MT, Ngeow YF, Lim WWD, Peh SC. Colon Carcinogenesis: The Interplay Between Diet and Gut Microbiota. Front Cell Infect Microbiol 2020;10:603086. [PMID: 33364203 DOI: 10.3389/fcimb.2020.603086] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
17 Thompson RS, Vargas F, Dorrestein PC, Chichlowski M, Berg BM, Fleshner M. Dietary prebiotics alter novel microbial dependent fecal metabolites that improve sleep. Sci Rep 2020;10:3848. [PMID: 32123201 DOI: 10.1038/s41598-020-60679-y] [Cited by in Crossref: 19] [Cited by in F6Publishing: 15] [Article Influence: 9.5] [Reference Citation Analysis]
18 Keely S, Talley NJ. Duodenal bile acids as determinants of intestinal mucosal homeostasis and disease. Neurogastroenterol Motil 2020;32:e13854. [PMID: 32323477 DOI: 10.1111/nmo.13854] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Kim SH, Chun HJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Lee HS, Um SH, Kim CD. Ursodeoxycholic acid attenuates 5-fluorouracil-induced mucositis in a rat model. Oncol Lett 2018;16:2585-90. [PMID: 30008943 DOI: 10.3892/ol.2018.8893] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
20 Xie AJ, Mai CT, Zhu YZ, Liu XC, Xie Y. Bile acids as regulatory molecules and potential targets in metabolic diseases. Life Sci 2021;287:120152. [PMID: 34793769 DOI: 10.1016/j.lfs.2021.120152] [Reference Citation Analysis]
21 Goossens J, Bailly C. Ursodeoxycholic acid and cancer: From chemoprevention to chemotherapy. Pharmacology & Therapeutics 2019;203:107396. [DOI: 10.1016/j.pharmthera.2019.107396] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 8.7] [Reference Citation Analysis]